Taking Stock
Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:45
- Mas informaciones
Informações:
Sinopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.
